Positions

Position Company Period
Chief Financial Officer, Executive Vice President Onyx Pharmaceuticals Inc Jan. 5, 2009 -
Independent Director Sunesis Pharmaceuticals Inc May 1, 2005 -
Independent Director Ultragenyx Pharmaceutical Inc Feb. 6, 2014 -
Independent Director Atara Biotherapeutics Inc March 1, 2014 -
Independent Director Crinetics Pharmaceuticals Inc Feb. 1, 2018 -
Independent Director MacroGenics Inc March 6, 2014 - May 14, 2020
Independent Director Dermira Inc April 1, 2014 - Feb. 20, 2020
Matthew Fust's trades of Ultragenyx Pharmaceutical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-18 2024-10-18
PS Planned sale
14,049 -41.1%
17.03
USD 239,319 		14,049 -41.1% 17.03 USD 239,319
2024-10-18 2024-10-17
PS Planned sale
7,739 -27.8%
17.01
USD 131,643 		7,739 -27.8% 17.01 USD 131,643
2024-03-22 2024-03-20
PS Planned sale
17,500 -48.6%
45.50
USD 796,250 		17,500 -48.6% 45.50 USD 796,250
2024-03-22 2024-03-20
PS Planned sale
17,500 -48.6%
43.58
USD 762,650 		17,500 -48.6% 43.58 USD 762,650
2024-03-22 2024-03-20
PS Planned sale
12,500 -40.3%
43.57
USD 544,625 		12,500 -40.3% 43.57 USD 544,625
2024-03-22 2024-03-20
PS Planned sale
12,500 -40.3%
43.57
USD 544,625 		12,500 -40.3% 43.57 USD 544,625
2024-03-11 2024-03-07
S Sale
7,500 -33.5%
50.88
USD 381,600 		7,500 -33.5% 50.88 USD 381,600
2024-03-11 2024-03-07
S Sale
2,145 -8.8%
50.85
USD 109,073 		2,145 -8.8% 50.85 USD 109,073
2024-03-11 2024-03-07
S Sale
2,550 -9.4%
50.89
USD 129,770 		2,550 -9.4% 50.89 USD 129,770
2022-07-15 2022-07-13
S Sale
5,700 -31.3%
20.96
USD 119,455 		5,700 -31.3% 20.96 USD 119,455
2021-11-05 2021-11-04
PS Planned sale
13,354 -29.8%
19.50
USD 260,403 		13,354 -29.8% 19.50 USD 260,403
2021-11-03 2021-11-01
S Sale
8,954 -41.7%
25.50
USD 228,327 		8,954 -41.7% 25.50 USD 228,327
2021-07-13 2021-07-12
S Sale
5,000 -28.5%
20.71
USD 103,550 		5,000 -28.5% 20.71 USD 103,550
2020-07-08 2020-07-06
PS Planned sale
6,181 -31.3%
90.00
USD 556,290 		6,181 -31.3% 90.00 USD 556,290
2020-07-06 2020-07-01
PS Planned sale
5,000 -27.0%
85.00
USD 425,000 		5,000 -27.0% 85.00 USD 425,000
2020-05-19 2020-05-18
PS Planned sale
1,875 -14.6%
75.00
USD 140,625 		1,875 -14.6% 75.00 USD 140,625
2020-04-24 2020-04-22
PS Planned sale
1,875 -12.7%
65.00
USD 121,875 		1,875 -12.7% 65.00 USD 121,875
2019-09-16 2019-09-12
US Dermira Inc (DERM)
S Sale
6,000 -35.2%
8.77
USD 52,636 		6,000 -35.2% 8.77 USD 52,636
2019-02-08 2019-02-06
PS Planned sale
6,924 -93.3%
29.38
USD 203,427 		6,924 -93.3% 29.38 USD 203,427
// ... existing code ... // ... rest of the file ...